Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/29/1993 | EP0575555A1 Protein-induced morphogenesis |
12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
12/29/1993 | EP0575546A1 Prad1 cyclin and its cdna |
12/29/1993 | EP0575539A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
12/29/1993 | EP0575537A1 Soluble cd28 proteins and methods of treatment therewith |
12/29/1993 | EP0575528A1 Response element compositions and assays employing same |
12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
12/29/1993 | EP0575485A1 Process for the development of binding mini-proteins |
12/29/1993 | EP0575452A1 Method for production of a vegetable protein hydrolyzate |
12/29/1993 | EP0575443A1 Pea protein hydrolyzate, method for production thereof and use thereof. |
12/29/1993 | EP0575407A1 Humanised antibodies having modified allotypic determinants |
12/29/1993 | EP0575357A1 Human follicle stimulating hormone receptor |
12/29/1993 | EP0575339A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
12/29/1993 | EP0575338A1 Multisite integration cassette for the genome of a yeast |
12/29/1993 | EP0575321A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
12/29/1993 | EP0538398A4 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
12/29/1993 | EP0454739B1 Method of recovering purified epi protein from a solution especially a fermentation solution |
12/29/1993 | EP0375743B1 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
12/29/1993 | EP0192671B1 Minactivin |
12/29/1993 | CN1079992A Neurotrophic factors having altered receptor binding specificities |
12/28/1993 | US5273966 Having two mannose residues attached to the threonine (29) amino acid |
12/28/1993 | CA1325612C Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
12/26/1993 | CA2099628A1 Anti-dcc gene product specific monoclonal antibody |
12/25/1993 | CA2099072A1 Kainate-binding, human cns receptors of the eaa4 family |
12/23/1993 | WO1993025701A1 Monoclonal antibody against human lung surfactant apoprotein d and use thereof |
12/23/1993 | WO1993025700A1 Monoclonal antibodies to glycoprotein p |
12/23/1993 | WO1993025690A1 Recombinant pseudomonas exotoxin with increased activity |
12/23/1993 | WO1993025689A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
12/23/1993 | WO1993025688A1 Recombinant production of saporin-containing proteins |
12/23/1993 | WO1993025687A1 Crystallization of m-csf |
12/23/1993 | WO1993025684A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
12/23/1993 | WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
12/23/1993 | WO1993025677A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS |
12/23/1993 | WO1993025676A1 METHOD FOR INCREASING PRODUCTION OF DISULFIDE BONDED RECOMBINANT PROTEINS BY $i(SACCHAROMYCES CEREVISIAE) |
12/23/1993 | WO1993025668A1 Leukotriene c4 synthase |
12/23/1993 | WO1993025664A1 Monoclonal antibody |
12/23/1993 | WO1993025637A1 Biocatalytic desulfurization of organosulfur molecules |
12/23/1993 | WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
12/23/1993 | WO1993025567A1 Production of recombinant polypeptides by bovine species and transgenic methods |
12/23/1993 | WO1993025237A1 Chimeric anti-cea antibody |
12/23/1993 | WO1993025233A1 Contraceptive vaccine |
12/23/1993 | WO1993025210A1 Diphtheria toxin vaccines |
12/23/1993 | WO1993025071A1 Production of human hemoglobin in transgenic pigs |
12/23/1993 | CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use |
12/23/1993 | CA2138038A1 Recombinant production of saporin-containing proteins |
12/23/1993 | CA2137911A1 Production of human hemoglobin in transgenic pigs |
12/23/1993 | CA2137799A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
12/23/1993 | CA2137656A1 Monoclonal antibody |
12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
12/23/1993 | CA2137077A1 Contraceptive vaccine |
12/23/1993 | CA2136724A1 Recombinant pseudomonas exotoxin with increased activity |
12/23/1993 | CA2134752A1 Monoclonal antibodies to glycoprotein p |
12/23/1993 | CA2115346A1 Chimeric anti-cea antibody |
12/22/1993 | EP0575054A2 Protein C derivatives |
12/22/1993 | EP0574955A1 Production and use of IL-6 |
12/22/1993 | EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof |
12/22/1993 | EP0574512A1 Redirection of cellular immunity by receptor chimeras |
12/22/1993 | EP0574506A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
12/22/1993 | EP0574461A1 High affinity humanized monoclonal antibodies |
12/22/1993 | EP0574414A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
12/22/1993 | EP0574406A1 Human dopamine d 4? receptor and its uses |
12/22/1993 | EP0574402A1 Expression of pace in host cells and methods of use thereof. |
12/22/1993 | EP0574395A1 Cytokine immunoconjugates |
12/22/1993 | EP0574391A1 Antibodies against the urokinase receptor and their use |
12/22/1993 | EP0482124B1 Somatotropin analogs |
12/22/1993 | EP0383777B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
12/22/1993 | CN1079780A 生产重组人体乳铁蛋白 Production of recombinant human lactoferrin |
12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
12/21/1993 | US5272085 Sodium tolerance genes derived from schizosaccharomyces pombe |
12/21/1993 | US5272066 Synthetic method for enhancing glycoprotein stability |
12/21/1993 | US5272064 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
12/21/1993 | US5272063 Process of making human nerve growth factor |
12/21/1993 | US5271912 Enzymatic processing of materials containing chromium and protein |
12/20/1993 | CA2098448A1 Dna fragments which encode the transferrin receptor subunits of neisseria meningitidis |
12/15/1993 | EP0574347A2 Novel fungal protease |
12/15/1993 | EP0574257A2 Amino-hydroxy-methyl-isoxazole-propionate binding human glutamate receptors |
12/15/1993 | EP0574048A2 Peptides and nucleic acid sequences related to Epstein Barr Virus |
12/15/1993 | EP0574029A1 Recombinant DNA molecules |
12/15/1993 | EP0573972A2 Method for measuring glycated hemoglobin |
12/15/1993 | EP0573768A2 Multiple bacteriocin producing lactococcus and compositions |
12/15/1993 | EP0573767A1 Process for production of exogenous gene or its product in plant cells |
12/15/1993 | EP0573624A1 Epitope mapping ot the c33c region of hcv |
12/15/1993 | EP0573616A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
12/15/1993 | EP0573613A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
12/15/1993 | EP0573611A1 Improved epitode displaying phage |
12/15/1993 | EP0573551A1 Serine-rich peptide linkers |
12/15/1993 | EP0573545A1 Monoclonal antibodies against receptor-induced binding sites |
12/15/1993 | EP0573540A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
12/15/1993 | EP0460016B1 Metastasis-associated collagenolytic metalloproteinases |
12/15/1993 | EP0378567B1 Synthetic yeast leader peptides |
12/15/1993 | EP0349569B1 BOVINE INTERLEUKIN-1$g(b) |
12/15/1993 | EP0209601B1 Recombinant colony stimulating factor-1 |
12/15/1993 | CN1079400A Anti-tumor method and anti-tumor agent |
12/14/1993 | US5270202 Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen |
12/14/1993 | US5270181 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
12/14/1993 | US5270176 Method for the selective cleavage of fusion proteins with lysostaphin |
12/14/1993 | US5270171 Cancer-associated SCM-recognition factor, preparation and method of use |
12/14/1993 | US5270165 Method of diagnosis of amyloidoses |